Zydus announces USFDA Orphan Drug Designation to Usnoflast for treatment of ALS
The company is committed to unlocking new frontiers in neuroscience and developing Usnoflast for patients with ALS
The company is committed to unlocking new frontiers in neuroscience and developing Usnoflast for patients with ALS
Expand the scope of the Production-Linked Incentive (PLI) scheme and increase its allocation to cover more pharmaceutical products and raw materials
This study will enrol 210 ALS patients and study doses of 50 mg and 75 mg Usnoflast versus placebo
The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
The overall clinical efficacy of Zaynich across indications was 98% at the test-of-cure
Modi remarked that more than 20 illustrious research institutions such as IISc, IITs, CSIR and DBT-BRIC have played a major role in this research
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
An investigational long-acting monoclonal antibody designed to protect infants from RSV disease during their first RSV season
Harnessing advanced data analysis for early detection, prevention and better outcomes
Subscribe To Our Newsletter & Stay Updated